Hormone replacement therapy in cancer survivors: A con opinion

Ca-A Cancer Journal for Clinicians

Volumn 46, Issue 6, 1996, Pages 365-373

  Rynowicz, Carolyn D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; GENETIC SUSCEPTIBILITY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0029832732     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.46.6.365     Document Type: Review

References (36)

1. Rosen PP, Groshen S, Kinne DW, Norton L: Factors influencing prognosis in node-negative breast carcinoma: Analysis of 767 TINOMO/T2NOMO patients with long-term follow-up. J Clin Oncol 1993;11:2090-2100.
2. Spicer DV, Pike MC: The prevention of breast cancer through reduced ovarian steroid exposure. Acta Oncol 1992;31:167-174.
3. Thomas DB, Persing JP, Hutchinson WB: Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. J Natl Cancer Inst 1982;69:1017-1025.
4. Horwitz KB: The molecular biology of RU486: Is there a role for antiprogestins in the treatment of breast cancer. Endocr Rev 1992;13:146-163.
5. Staffa JA, Newschaffer CJ, Jones JK, Miller V: Progestins and breast cancer: an epidemiologic review. Fertil Steril 1992;57:473-491.
6. Irwin KL, Lee NC, Peterson HB, et al: Hysterectomy, tubal sterilization, and the risk of breast cancer. Am J Epidemiol 1988;127:1192-1201.
7. Kelsey JL: Breast cancer epidemiology: Summary and future directions. Epidemiol Rev 1993;15:256-263.
8. Scottish Cancer Trials Breast Group and ICRF Breast Unit, Guy's Hospital, London: Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: The Scottish Trial. Lancet 1993;341:1293-1298.
9. Early Breast Cancer Trialists Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992;339:71-85.
10. Bianco AR, Del Mastro L, Gallo C, et al: Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. Br J Cancer 1991;63:799-803.
11. Steinberg KK, Thacker SB, Smith SJ, et al: A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-1990.
12. Grady D, Ernster V: Invited commentary: Does postmenopausal hormone therapy cause breast cancer? Am J Epidemiol 1991;134:1396-1400.
13. Hemminki E, Sihvo S: A review of postmenopausal hormone therapy recommendations: Potential for selection bias. Obstet Gynecol 1993;82:1021-1028.
14. Colditz GA, Egan KM, Stampfer MJ: Hormone replacement therapy and risk of breast cancer: Results from epidemiologic studies. Am J Obstet Gynecol 1993;168:1473-1480.
15. Colditz GA, Stampfer MJ, Willett WC, et al: Prospective study of estrogen replacement therapy and risk of breasl cancer in postmenopausal women. JAMA 1990;264:2648-2653.
16. Hunt K, Vessey M, McPherson K, Coleman M: Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 1987;94:620-635.
17. Mills PK, Beeson WL, Phillips RL, Fraser GE: Prospective study of exogenous hormone use and breast cancer in Seventh-Day Adventists. Cancer 1989;64:591-597.
18. Colton T, Greenberg ER, Noller K, et al: Breast cancer in mothers prescribed diethylstilbestrol in pregnancy: Further follow-up. JAMA 1993;269:2096-2100.
19. White E, Malone KE, Weiss NS, Daling JR: Breast cancer among young U.S. women in relation to oral contraceptive use. J Natl Cancer Inst 1994;86:505-514.
20. Eden JA: Oestrogen and the breast: 1. Myths about estrogen and breast cancer. Med J Aust 1992;157:175-177.
21. Lippman M, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976;36:4595-4601.
22. Ewertz M, Storm HH: Multiple primary cancers of the breast, endometrium and ovary. Eur J Cancer Clin Oncol 1989;25:1927-1932.
23. Reimer RR, Hoover R, Fraumeni JF Jr, Young RC: Second primary neoplasms following ovarian cancer. J Natl Cancer Inst 1978;61:1195-1197.
24. Mauvais-Jarvis P, Kuttenn F, Gompel A: Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat 1986;8:179-187.
25. Guinee VF, Olsson H, Moller T, et al: Effect of pregnancy on prognosis for young women with breast cancer. Lancet 1994;343:1587-1589.
26. Lambe M, Hsieh C, Trichopoulos D, et al: Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5-9.
27. Stoll BA: Hormone replacement therapy in women treated for breast cancer. Eur J Cancer Clin Oncol 1989;25:1909-1913.
28. Wile AG, Opfell RW, Margileth DA: Hormone replacement therapy in previously treated breast cancer patients. Am J Surg 1993;165:372-375.
29. American College of Obstetrics and Gynecology: Committee opinion: Estrogen replacement therapy in women with previously treated breast cancer. Number 1994;135:1-4.
30. American College of Physicians: Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992;117:1038-1041.
31. Hulka B: Effect of exogenous estrogen on postmenopausal women: The epidemiologic evidence. Obstet Gynecol Surv 1980;35:389-399.
32. Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL: Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol 1986;67:326-330.
33. Lee RB, Burke TW, Park RC: Estrogen replacement therapy following treatment for Stage I endometrial carcinoma. Gynecol Oncol 1990;36:189-191.
34. Bryant GW: Administration of estrogens to patients with a previous diagnosis of endometrial adenocarcinoma (letter). South Mod J 1990;83:725-726.
35. Baker DP: Estrogen-replacement therapy in patients with previous endometrial carcinoma. Compr Ther 1990;16:28-35.
36. American College of Obstetricians and Gynecologists: Committee Opinion. Estrogen replacement therapy and endometrial cancer. Number 126, 1993.